Perlmutter Cancer Center at NYU Langone Health

New York, New York 10016

3 studies enrolling now · 6 studies all time

What they study most

Advanced Solid Tumors, Bladder Urothelial Carcinoma, Cholangiocarcinoma, Colorectal Cancer, Colorectal Cancer (CRC), Endometrial Cancer, Esophageal Cancer, Fallopian Tube Cancer, Gastric Cancer, Head and Neck Cancer, Hepatic Cancer, Multiple Myeloma

Studies at this site

• A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma — Recruiting now
• Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS — Recruiting now
• Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence — Recruiting now
• Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma — Running, not enrolling
• A Study of CDX-585 in Patients With Advanced Malignancies — Completed
• Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced Pancreatic Adenocarcinoma — Stopped early